Results 21 to 30 of about 5,080,573 (227)

Mantle-cell lymphoma

open access: yesAnnals of Oncology, 1994
Histological subtyping of non-Hodgkin's lymphomas is of prognostic significance. Current classification systems subdivide them into low-, intermediate-, and high-grade malignancies. These subgroups are largely supported by clinical findings, but immunophenotyping and genotyping have shown that several of these histologically defined subcategories are ...
C, De Wolf-Peeters, S, Pittaluga
openaire   +4 more sources

Bilateral vision loss as the initial presentation for central nervous system involvement of mantle cell lymphoma: A case series

open access: yesAmerican Journal of Ophthalmology Case Reports, 2021
Purpose: Mantle cell lymphoma is a rare aggressive subtype of non-Hodgkins B cell lymphoma. It typically presents with asymptomatic monoclonal lymphocytosis, lymphadenopathy or bulky extranodal disease.
L. Small   +4 more
doaj   +1 more source

The potential therapeutic role of selenium in diffuse large B-cell lymphoma [PDF]

open access: yes, 2011
PhDThe clinical background to this work confirms the very poor outcome of patients with recurrent diffuse large B-cell lymphoma (DLBCL) and highlights the need for better therapies.
Kassam, Shireen
core   +4 more sources

Mantle cell lymphoma presenting with severe upper gastrointestinal bleeding

open access: yesMedicine, 2022
. Introduction:. Although it usually involves extranodal sites such as the gastrointestinal tract in more than 80% of cases, mantle cell lymphoma is considered a rare cause of gastrointestinal bleeding, especially severe and life-threatening bleeding ...
Khaled Ali, MD   +3 more
doaj   +1 more source

Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways

open access: yesHaematologica, 2012
Background There is increasing evidence that stromal cell interactions are required for the survival and drug resistance of several types of B-cell malignancies.
Daniel J. Medina   +5 more
doaj   +1 more source

Suboccipital lateral injection of intrathecal chemotherapy in a patient with mantle cell lymphoma [PDF]

open access: yes, 2004
Background: Even today patients who suffer from mantle cell lymphoma have a poor prognosis, especially when the CNS is involved. To confirm the diagnosis of meningeosis lymphomatosa, asservation of the liquor cerebrospinalis is necessary.
Dühmke, Eckhart   +3 more
core   +1 more source

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

open access: yesHaematologica, 2009
Background Cyclin D1-negative mantle cell lymphoma is difficult to distinguish from other small B-cell lymphomas. The clinical and pathological characteristics of patients with this form of lymphoma have not been well defined.
Ana Mozos   +23 more
doaj   +1 more source

Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma [PDF]

open access: yes, 2011
Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known.
Campo Elías   +37 more
core   +1 more source

Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells

open access: yesHaematologica, 2013
Clinical trials of immunotherapy in mantle cell lymphoma have not yet delivered desirable results, partly because of the inhibitory machinery of the tumor and its microenvironment.
Lijuan Wang   +14 more
doaj   +1 more source

In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior

open access: yesHaematologica, 2012
Background Cyclin D1-positive B cells are occasionally found in the mantle zones of reactive lymphoid follicles, a condition that has been called “in situ mantle cell lymphoma”.
Alejandra Carvajal-Cuenca   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy